Stocks-MRK-Merck & Co.

MRK Merck & Co.

105.53 -1.40 (-1.31%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Stocks-MRK-Merck & Co.
MRK Merck & Co.
Invest

Performance

0% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
267.9B
Day’s Range
105.28
-
106.85
52W Range
80.65
-
115.30
Volume (3M)
8.82M
Price-Earnings Ratio
18.47
Revenue
58.47B

Merck & Co. Latest News

View All
Merck showcases how its IT, digital, and data functions drive innovation and business valueMerck showcases how its IT, digital, and data functions drive innovation and business valueYourStoryabout 5 hours agoMerck Releases Keytruda Data In Frontline Endometrial Cancer PatientsMerck Releases Keytruda Data In Frontline Endometrial Cancer PatientsEIN News Lung Cancerabout 20 hours agoMerck touts PhIII Keytruda data in frontline endometrial cancerMerck touts PhIII Keytruda data in frontline endometrial cancerEndpoints Newsa day ago
Pinned Post
eToro Team
eToro
6 days ago
📰 EXTRA EXTRA…New charts arrived on eToro! Today we would like to give an official welcome to our new charts, in partnership with TradingView, one of the market leaders in charting and analysis tools. Yes, we know! You have already noticed the change but now we want to share with you what this complete... Show More
Like CommentShare
Show more comments2 of 92
null
.
Top Discussions

About Merck & Co.

Merck Inc is a leading global healthcare company and is the main company of The Merck Group, a German multinational corporation headquartered in Darmstadt, Germany. The group was founded in 1668, making it the oldest pharmaceutical and chemical company in the world, and now includes around 250 companies in total, employing 57,000 people worldwide. The firm serves a global customer base, with a presence in 66 countries. The firm’s corporate headquarters are in Kenilworth, New Jersey. Merck Inc. operates across multiple sectors, including healthcare, life sciences and performance materials. The firm’s healthcare innovations span many areas, such as endocrinology, oncology, fertility, general medicine, and neurodegenerative diseases. The firm also researches cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. The firm offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck is also involved in the development of performance materials across various different sectors, such as architecture, functional solutions, semi-conductors and opto-electronics. The company went public in 1995, and trades on the NYSE where it is listed under the stock ticker MRK. If you want to track the value of this company, simply add MRK stock to your eToro watchlist.
69K
Employees
Kenilworth, New Jersey, US
HQ
1891
Founded
Robert M. Davis, MBA
CEO
Show More
Med TechNYSE

Upcoming Earnings

27
APR
REPORTS
Merck & Co. Q1 2023 earnings report is expected to be released before market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
119.80
Based on 10 analysts who covered MRK 

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a company’s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
49
Medium
Industry 
Avg. 47 
63
Environment
60
Social
35
Governance

People Also Bought